David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 319



211
TITLE: Pharmacotherapy of endometrial cancer
AUTHORS: Nicanor I Barrena Medel; Sharmilee Bansal; David Scott Miller ; Jason D Wright; Thomas J Herzog;
PUBLISHED: 2009, SOURCE: Expert Opinion on Pharmacotherapy, VOLUME: 10, ISSUE: 12
INDEXED IN: Scopus CrossRef: 17
IN MY: ORCID | CIÊNCIAVITAE
212
TITLE: Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
AUTHORS: David Scott Miller ; John A Blessing; Carolyn N Krasner; Robert S Mannel; Parviz Hanjani; Michael L Pearl; Steven E Waggoner; Cecelia H Boardman;
PUBLISHED: 2009, SOURCE: Journal of Clinical Oncology, VOLUME: 27, ISSUE: 16
INDEXED IN: Scopus CrossRef: 141
IN MY: ORCID | CIÊNCIAVITAE
213
TITLE: Recent progress: Gynecologic oncology group trials in uterine corpus tumors
AUTHORS: Louise P King; David Scott Miller ;
PUBLISHED: 2009, SOURCE: Reviews on Recent Clinical Trials, VOLUME: 4, ISSUE: 2
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
214
TITLE: Somatic LKB1 mutations promote cervical cancer progression  Full Text
AUTHORS: Shana N Wingo; Teresa D Gallardo; Esra A Akbay; Mei Chi Liang; Cristina M Contreras; Todd Boren; Takeshi Shimamura; David Scott Miller ; Norman E Sharpless; Nabeel Bardeesy; David J Kwiatkowski; John O Schorge; Kwok Kin Wong; Diego H Castrillon;
PUBLISHED: 2009, SOURCE: PLoS ONE, VOLUME: 4, ISSUE: 4
INDEXED IN: Scopus CrossRef: 219
IN MY: ORCID | CIÊNCIAVITAE
215
216
TITLE: Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group  Full Text
AUTHORS: David Scott Miller ; John A Blessing; Diane C Bodurka; Albert J Bonebrake; John O Schorge;
PUBLISHED: 2008, SOURCE: Gynecologic Oncology, VOLUME: 110, ISSUE: 1
INDEXED IN: Scopus CrossRef: 49
IN MY: ORCID | CIÊNCIAVITAE
217
TITLE: Gynecologic oncology group trials in uterine corpus malignancies: recent progress
AUTHORS: David Scott Miller ; Louise P King;
PUBLISHED: 2008, SOURCE: Journal of Gynecologic Oncology, VOLUME: 19, ISSUE: 4
INDEXED IN: CrossRef: 16
IN MY: ORCID | CIÊNCIAVITAE
218
TITLE: Implications of EGFR inhibition in ovarian cancer cell proliferation  Full Text
AUTHORS: Shawna L Bull Phelps; John O Schorge; Michael J Peyton; Hisayuki Shigematsu; Li Lin Xiang; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2008, SOURCE: Gynecologic Oncology, VOLUME: 109, ISSUE: 3
INDEXED IN: Scopus CrossRef: 32
IN MY: ORCID | CIÊNCIAVITAE
219
TITLE: Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix  Full Text
AUTHORS: Shawna L Bull Phelps; Elizabeth I O Garner; Christine S Walsh; Paola A Gehrig; David Scott Miller ; John O Schorge;
PUBLISHED: 2007, SOURCE: Gynecologic Oncology, VOLUME: 107, ISSUE: 2
INDEXED IN: Scopus CrossRef: 39
IN MY: ORCID | CIÊNCIAVITAE
220
TITLE: Multi-institutional retrospective analysis of lymphadenectomy in early stage adenocarcinoma of the cervix  Full Text
AUTHORS: SCHLUMBRECHT, M; KNOWLES, L; David Scott Miller ; SCHORGE, J;
PUBLISHED: 2007, SOURCE: Gynecologic Oncology, VOLUME: 107, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
Page 22 of 32. Total results: 319.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service